Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.

Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.

FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.

We haven't written up this one. MarketWatch Top has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at marketwatch.com →

More in Health & Medicine

Uganda: How Uganda Is Preparing Against the Threat of Arboviral Diseases

[Malaria Consortium] Arboviruses are viruses carried by mosquitoes and ticks and passed to people when they are bitten. Many arboviruses were first identified in East Africa, where they remain a…

  • Six arboviruses, including dengue and Zika, threaten Uganda.
  • Rapid urbanization, climate change, and population movement increase risk.
  • SUPAAT project aims to enhance surveillance, testing, and policy.

More from Wednesday 23 September →